Heart Failure Management: A 2016 Update
List two new drug classes approved in 2015 for the treatment of heart failure. List two specific goals for patient education regarding risk and benefit for these new therapies.
Identify the indications for the use of ivabradine. Identify the indications for the use of the combination agent sacubitril/valsartan in the patient with heart failure.
1.0 Free CEUs for Advanced Nurse Practitioners which includes 1.0 Free Hours of Pharmacology
Expires 9/2017